Compare NIO Inc. (NIO) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs Repligen Corporation Common Stock — how do they compare? NIO Inc. trades at $3.39 (market cap $8.76B), while Repligen Corporation Common Stock trades at $178.2 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and Repligen Corporation Common Stock for 0 Days on average.
| NIO | RGEN | |
|---|---|---|
Market Cap | $8.76B | $11.31B |
Volume | 36,159,487 | 1,216,919 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.42 | $194.57 |
52-Week Low | $3.37 | $102.87 |
Typical Hold Time | 81 Days | 0 Days |
Enterprise Value | $6.65B | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.56, up 2.59% today, but remains near 52-week lows amid a bearish technical trend. The company reported Q3 2026 deliveries up 25.4% and has beaten EPS estimates for three consecutive quarters, yet continues to post net losses with a -4.17% margin. A strategic battery-swap partnership with Geely aims to expand network utilization, valued at $2.38 billion, though it initially weighed on the stock. Revenue growth is robust, reaching $87.49 billion in 2025, but profitability challenges and high debt levels persist.
The outlook is mixed: analyst consensus is bullish with a $6.23 price target, but execution risks in a competitive EV market and persistent cash burn pose significant hurdles. Upside depends on margin improvement and successful scaling of the battery-swap ecosystem, while downside risks include prolonged losses and industry price wars.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
